Healio
Healio
Trial Scorecards Banner Image

Trial Scorecards
Issue: September 2013
September 01, 2013
1 min read
Save

RELY-ABLE

Issue: September 2013
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Follow-up of the RE-LY study to further assess the efficacy and safety of two doses of dabigatran for prevention of stroke or systemic embolism in patients with AF.

RELY-ABLE

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.